mci 9038 has been researched along with Coronary Disease in 25 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (12.00) | 18.7374 |
| 1990's | 8 (32.00) | 18.2507 |
| 2000's | 14 (56.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Breddin, HK | 1 |
| Bates, ER; Weitz, JI | 1 |
| Califf, RM; O'Shea, S; Reddan, D; Szczech, LA | 1 |
| Kaplan, KL | 1 |
| Lewis, BE; Walenga, JM | 1 |
| Lincoff, AM | 1 |
| Jang, IK; Kathiresan, S; Wykrzykowska, JJ | 1 |
| Daikoku, S; Goto, Y; Itoh, A; Itoh, T; Miyazaki, S; Morii, I; Nonogi, H | 1 |
| Bhatt, DL; Gurm, HS | 1 |
| Jang, IK; Kleiman, NS; Lewis, BE; Matthai, WH | 1 |
| Hursting, MJ; Kelton, JG; Lewis, BE; Matthai, WH | 1 |
| Herrman, JP; Serruys, PW | 1 |
| Donkin, J; Iaffaldano, R; Lewis, BE; McKiernan, TL; Rao, L; Wallenga, JM | 1 |
| Arita, M; Hamada, M; Hano, T; Imanishi, T; Nishio, I; Tomobuchi, Y | 1 |
| Fujii, K; Koide, M; Matsuo, M; Matsuo, T; Sakamoto, S; Suzuki, S | 1 |
| Matthai, WH | 1 |
| Endo, H; Fujiki, T; Ide, H; Imamura, K; Sato, M; Sudo, K | 1 |
| Dager, WE; White, RH | 1 |
| Wittkowsky, AK | 1 |
| Hirase, T; Kario, K; Kobayashi, H; Matsuo, T; Miki, T; Sakamoto, S; Yamada, T | 1 |
| Collen, D; Fallon, JT; Gold, HK; Guerrero, JL; Holt, R; Jang, IK; Leinbach, RC; Yaoita, H; Yasuda, T | 1 |
| Chesebro, JH; Fuster, V | 1 |
| Fitzgerald, DJ; Fitzgerald, GA | 1 |
| Allison, P; Ashton, J; Buja, LM; Eidt, JF; Golino, P; McNatt, J; Noble, S; Willerson, JT | 2 |
9 review(s) available for mci 9038 and Coronary Disease
| Article | Year |
|---|---|
[Experimental and clinical results with the thrombin inhibitor Argatroban].
Topics: Animals; Anticoagulants; Antithrombins; Arginine; Coronary Disease; Heparin; Humans; Pipecolic Acids; Sulfonamides; Thrombocytopenia | 2002 |
Direct thrombin inhibitors in cardiac disease.
Topics: Arginine; Coronary Disease; Fibrinolytic Agents; Hirudin Therapy; Hirudins; Humans; Peptide Fragments; Pipecolic Acids; Randomized Controlled Trials as Topic; Recombinant Proteins; Sulfonamides; Thrombin | 2003 |
Direct thrombin inhibitors.
Topics: Antithrombins; Arginine; Coronary Disease; Half-Life; Hirudins; Humans; Metabolic Clearance Rate; Peptide Fragments; Pipecolic Acids; Recombinant Proteins; Sulfonamides; Thrombin; Venous Thrombosis | 2003 |
Argatroban in HIT type II and acute coronary syndrome.
Topics: Anticoagulants; Arginine; Cardiac Surgical Procedures; Coronary Disease; Humans; Myocardial Infarction; Pipecolic Acids; Sulfonamides; Thrombocytopenia | 2002 |
Direct thrombin inhibitors for non-ST-segment elevation acute coronary syndromes: what, when, and where?
Topics: Angioplasty, Balloon, Coronary; Arginine; Clinical Trials as Topic; Coronary Disease; Fibrinolytic Agents; Heparin; Hirudin Therapy; Hirudins; Humans; Myocardial Infarction; Peptide Fragments; Pipecolic Acids; Recombinant Proteins; Sulfonamides; Syndrome; Thrombin; Thrombolytic Therapy | 2003 |
Thrombin, an ideal target for pharmacological inhibition: a review of direct thrombin inhibitors.
Topics: Acute Disease; Angioplasty, Balloon, Coronary; Anticoagulants; Arginine; Atrial Fibrillation; Azetidines; Benzylamines; Clinical Trials as Topic; Coronary Disease; Heparin; Hirudins; Humans; Myocardial Infarction; Peptide Fragments; Pipecolic Acids; Recombinant Proteins; Sulfonamides; Syndrome; Thrombin; Thromboembolism; Thrombosis; Venous Thrombosis | 2005 |
Thrombin and antithrombotic therapy in interventional cardiology.
Topics: Angioplasty, Balloon, Coronary; Animals; Antithrombins; Arginine; Coronary Disease; Fibrinolytic Agents; Heparin; Hirudin Therapy; Humans; Pipecolic Acids; Platelet Membrane Glycoproteins; Recurrence; Sulfonamides; Thrombin | 1994 |
Treatment of heparin-induced thrombocytopenia.
Topics: Animals; Anticoagulants; Arginine; Chondroitin Sulfates; Clinical Trials as Topic; Coronary Disease; Dermatan Sulfate; Drug Combinations; Female; Heparin; Heparitin Sulfate; Hirudin Therapy; Hirudins; Humans; Pipecolic Acids; Pregnancy; Rabbits; Recombinant Proteins; Sulfonamides; Thrombocytopenia | 2002 |
The role of thrombin inhibition during percutaneous coronary intervention.
Topics: Angioplasty, Balloon, Coronary; Arginine; Clinical Trials as Topic; Coronary Disease; Coronary Thrombosis; Fibrinolytic Agents; Fondaparinux; Heparin; Hirudins; Humans; Peptide Fragments; Pipecolic Acids; Polysaccharides; Recombinant Proteins; Sulfonamides; Thrombin | 2002 |
2 trial(s) available for mci 9038 and Coronary Disease
| Article | Year |
|---|---|
Local delivery of argatroban for the prevention of restenosis after coronary balloon angioplasty: a prospective randomized pilot study.
Topics: Aged; Angioplasty, Balloon; Arginine; Coronary Angiography; Coronary Disease; Coronary Restenosis; Female; Follow-Up Studies; Humans; Male; Middle Aged; Pipecolic Acids; Platelet Aggregation Inhibitors; Risk Factors; Sulfonamides; Time Factors | 2004 |
Argatroban anticoagulation in patients with a history of heparin-induced thrombocytopenia.
Topics: Adult; Aged; Aged, 80 and over; Arginine; Coronary Disease; Female; Heparin; Humans; Male; Middle Aged; Pipecolic Acids; Pulmonary Embolism; Sulfonamides; Thrombocytopenia; Treatment Outcome; Venous Thrombosis | 2005 |
14 other study(ies) available for mci 9038 and Coronary Disease
| Article | Year |
|---|---|
Anticoagulation in acute cardiac care in patients with chronic kidney disease.
Topics: Anticoagulants; Antithrombins; Arginine; Chronic Disease; Coronary Disease; Heparin; Heparin, Low-Molecular-Weight; Hirudin Therapy; Hirudins; Humans; Kidney Diseases; Peptide Fragments; Pipecolic Acids; Recombinant Proteins; Sulfonamides; United States | 2003 |
Clinician update: direct thrombin inhibitors in acute coronary syndromes.
Topics: Acute Disease; Arginine; Coronary Disease; Fibrinolytic Agents; Hirudin Therapy; Hirudins; Humans; Peptide Fragments; Pipecolic Acids; Recombinant Proteins; Sulfonamides; Thrombin | 2003 |
Argatroban anticoagulation in conjunction with glycoprotein IIb/IIIa inhibition in patients undergoing percutaneous coronary intervention: an open-label, nonrandomized pilot study.
Topics: Aged; Angioplasty, Balloon, Coronary; Anticoagulants; Arginine; Coronary Disease; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Pilot Projects; Pipecolic Acids; Platelet Glycoprotein GPIIb-IIIa Complex; Sulfonamides | 2004 |
Report of successful use of argatroban as an alternative anticoagulant during coronary stent implantation in a patient with heparin-induced thrombocytopenia and thrombosis syndrome.
Topics: Aged; Angioplasty, Balloon, Coronary; Arginine; Coronary Angiography; Coronary Disease; Female; Heparin; Humans; Myocardial Infarction; Pipecolic Acids; Platelet Aggregation Inhibitors; Stents; Sulfonamides; Syndrome; Thrombocytopenia; Thrombosis | 1996 |
Effects of locally administered argatroban on restenosis after balloon angioplasty: experimental and clinical study.
Topics: Angioplasty, Balloon; Animals; Antithrombins; Arginine; Cell Division; Coronary Disease; Humans; Muscle, Smooth, Vascular; Pipecolic Acids; Platelet Activation; Rabbits; Sulfonamides | 1997 |
Effective anticoagulation by argatroban during coronary stent implantation in a patient with heparin-induced thrombocytopenia.
Topics: Anticoagulants; Antithrombins; Arginine; Coronary Disease; Heparin; Humans; Male; Middle Aged; Pipecolic Acids; Stents; Sulfonamides; Thrombocytopenia | 1997 |
Use of argatroban during percutaneous coronary interventions in patients with heparin-induced thrombocytopenia.
Topics: Angioplasty, Balloon, Coronary; Anticoagulants; Arginine; Coronary Disease; Drug Evaluation; Heparin; Humans; Pipecolic Acids; Sulfonamides; Thrombocytopenia; Thrombosis | 1999 |
Off-pump coronary artery bypass for a heparin-allergic patient.
Topics: Anticoagulants; Arginine; Coronary Angiography; Coronary Artery Bypass; Coronary Disease; Drug Hypersensitivity; Heparin; Humans; Male; Middle Aged; Pipecolic Acids; Sulfonamides | 2001 |
Hereditary heparin cofactor II deficiency and coronary artery disease.
Topics: Angina Pectoris; Angiography; Angioplasty, Balloon, Coronary; Antithrombins; Arginine; Coronary Disease; Female; Heparin Cofactor II; Humans; Male; Middle Aged; Pedigree; Pipecolic Acids; Sulfonamides | 1992 |
Comparative effects of aspirin, a synthetic thrombin inhibitor and a monoclonal antiplatelet glycoprotein IIb/IIIa antibody on coronary artery reperfusion, reocclusion and bleeding with recombinant tissue-type plasminogen activator in a canine preparation
Topics: Animals; Antibodies, Monoclonal; Antithrombins; Arginine; Aspirin; Coronary Circulation; Coronary Disease; Coronary Thrombosis; Dogs; Pipecolic Acids; Platelet Membrane Glycoproteins; Recurrence; Sulfonamides; Thrombolytic Therapy; Tissue Plasminogen Activator; Vascular Patency | 1990 |
Reperfusion, specific thrombin inhibition and reocclusion after thrombolysis.
Topics: Animals; Antibodies, Monoclonal; Antithrombins; Arginine; Coronary Disease; Coronary Thrombosis; Dogs; Pipecolic Acids; Platelet Membrane Glycoproteins; Recurrence; Sulfonamides; Thrombolytic Therapy; Tissue Plasminogen Activator | 1990 |
Role of thrombin and thromboxane A2 in reocclusion following coronary thrombolysis with tissue-type plasminogen activator.
Topics: Animals; Antithrombins; Arginine; Coronary Disease; Coronary Thrombosis; Disease Models, Animal; Dogs; Phospholipases; Phospholipases A; Pipecolic Acids; Platelet Aggregation; Reperfusion; Sulfonamides; Thrombin; Tissue Plasminogen Activator | 1989 |
Thrombin is an important mediator of platelet aggregation in stenosed canine coronary arteries with endothelial injury.
Topics: Animals; Antithrombin III; Arginine; Bridged Bicyclo Compounds, Heterocyclic; Coronary Circulation; Coronary Disease; Coronary Vessels; Dogs; Electrophoresis, Polyacrylamide Gel; Endothelium, Vascular; Fatty Acids, Unsaturated; Female; Hemodynamics; Heparin; Hydrazines; Ketanserin; Male; Peptide Hydrolases; Pipecolic Acids; Platelet Aggregation; Sulfonamides; Thrombin | 1989 |
Thrombin is an important mediator of cyclic coronary blood flow variations due to platelet aggregation in stenosed canine coronary arteries.
Topics: Animals; Antithrombins; Arginine; Bridged Bicyclo Compounds, Heterocyclic; Coronary Circulation; Coronary Disease; Dogs; Fatty Acids, Unsaturated; Female; Heparin; Hydrazines; Ketanserin; Male; Pipecolic Acids; Platelet Aggregation; Sulfonamides; Thrombin; Thromboxane A2 | 1988 |